Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Multivariate Behavioral Research|January 23, 2016
SOME NOTES ON THE NUMBER OF FACTORS PROBLEMA R Hakstian, V J Muller
Carbohydrate Research|October 28, 1983
Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidaseJ J Hopwood, V J Muller
Clinical Genetics|November 1, 1984
alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfateV J Muller, J J Hopwood
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 9, 2001
An Australasian diagnostic service for the neuronal ceroid lipofuscinosesV J Muller, B C Paton, M J Fietz
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1983
"Whey" proteins of milk of the red (Macropus rufus) and eastern grey (Macropus giganteus) kangarooH A McKenzie, V J Muller, G B Treacy
The Journal of Clinical Investigation|February 14, 1998
Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypesA C Crawley, G Yogalingam, V J Muller, et al.
The Biochemical Journal|March 15, 1986
Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activityJ J Hopwood, H Elliott, V J Muller, et al.
New Zealand Veterinary Journal|July 21, 2005
Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxiaR D Jolly, F J Allan, M G Collett, et al.
American Journal of Human Genetics|April 1, 1992
Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patientsL J Ashton, D A Brooks, P A McCourt, et al.
Human Mutation|August 10, 2004
Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapyG Yogalingam, X-H Guo, V J Muller, et al.
Pageof 2